Recent developments with Fate Therapeutics Inc (FATE) have led to the company’s beta value being reach 2.03 cents.
On Tuesday, Fate Therapeutics Inc (NASDAQ: FATE) opened lower -5.11% from the last session, before settling in for the closing price of $1.37. Price fluctuations